Advanced Breast Cancer Clinical Trials

ReadTheTrial indexes 6 studies for Advanced Breast Cancer. The most common development stage is Phase 2 (4 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

6 clinical trials found for Advanced Breast Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 4
67%
Phase 3 1
17%
Phase 4 1
17%

Trial Status Breakdown

Trials for Advanced Breast Cancer

A Randomized Phase II Study to Evaluate the Safety and Efficacy of Trastuzumab Deruxtecan Versus CDK4/6 Inhibitor-based Endocrine Therapy as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype According to Gene Expression Profiling.

NCT06486883 · RECRUITING · Phase 2

A Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Elacestrant Plus Everolimus Versus Elacestrant in Patients With ER+/HER2-, ESR1mut Advanced Breast Cancer Progressing to Endocrine Therapy and CDK4/6 Inhibitors

NCT06382948 · RECRUITING · Phase 3

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer：A Prospective, Open-label, Phase 2 Trial

NCT06649331 · RECRUITING · Phase 2

ALPelisib INdia Safety STudy (ALPINIST): A Phase IV, Prospective, Multicenter, Open-label, Non-comparative, Interventional Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR Positive, HER2-negative, Advanced Breast Cancer (aBC) With a PIK3CA Mutation, Whose Disease Has Progressed on or After Endocrine Based Treatment.

NCT05631795 · COMPLETED · Phase 4

A Phase II Open-label, 2-Part, Multi-center Study of BYL719 (Alpelisib) in Combination With Fulvestrant for Men and Postmenopausal Women With PIK3CA Mutation Hormone Receptor (HR) Positive, HER2-negative, Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor (AI) Treatment in Japan

NCT04524000 · ACTIVE NOT RECRUITING · Phase 2

Exploratory Clinical Study of PD-1 Knockout Targeting MUC1 CAR-T Cells (AJMUC1) in the Treatment of MUC1-positive Advanced Breast Cancer

NCT05812326 · COMPLETED · Phase 2

Frequently Asked Questions

What clinical trials are available for Advanced Breast Cancer?

There are 6 clinical trials listed for Advanced Breast Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Advanced Breast Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Advanced Breast Cancer trials in?

Current Advanced Breast Cancer trials are distributed across: Phase 2 (4), Phase 3 (1), Phase 4 (1).

Find More Trials